Although there are many studies describing the clinical outcome of arterial involvement/infiltration of SMA or CHA in borderline resectable and locally advanced pancreatic cancer, there are only a handful of studies describing the significance of the involvement of the aRHA in BR PDAC [8-11]. This evidence concerns the gene TCFL5 and familial pancreatic carcinoma.